Literature DB >> 36066730

The longitudinal evolution of cerebral blood flow in children with tuberous sclerosis assessed by arterial spin labeling magnetic resonance imaging may be related to cognitive performance.

Rima Nabbout1,2, Nathalie Boddaert3,4, Caroline Rutten5,1, Ludovic Fillon1, Mathieu Kuchenbuch1,2, Ana Saitovitch1, Jennifer Boisgontier1, Nicole Chemaly1,2, Delphine Breuillard2, Lisa Ouss6, Volodia Dangouloff-Ros5,1, Thomas Blauwblomme1,7, Monica Zilbovicius1.   

Abstract

OBJECTIVE: To study longitudinal changes in tuber and whole-brain perfusion in children with tuberous sclerosis complex (TSC) using arterial spin labeling (ASL) perfusion MRI and correlate them with pathological EEG slow wave activity and neurodevelopmental outcomes.
METHODS: Retrospective longitudinal cohort study of 13 children with TSC, 3 to 6 serial ASL-MRI scans between 2 months and 7 years of age (53 scans in total), and an EEG examination performed within 2 months of the last MRI. Tuber cerebral blood flow (CBF) values were calculated in tuber segmentation masks, and tuber:cortical CBF ratios were used to study tuber perfusion. Logistic regression analysis was performed to identify which initial tuber characteristics (CBF value, volume, location) in the first MRI predicted tubers subsequently associated with EEG slow waves. Whole-brain and lobar CBF values were extracted for all patient scans and age-matched controls. CBF ratios were compared in patients and controls to study longitudinal changes in whole-brain CBF.
RESULTS: Perfusion was reduced in tubers associated with EEG slow waves compared with other tubers. Low tuber CBF values around 6 months of age and large tuber volumes were predictive of tubers subsequently associated with EEG slow waves. Patients with severe developmental delay had more severe whole-brain hypoperfusion than those with no/mild delay, which became apparent after 2 years of age and were not associated with a higher tuber load.
CONCLUSIONS: Dynamic changes in tuber and brain perfusion occur over time. Perfusion is significantly reduced in tubers associated with EEG slow waves. Whole-brain perfusion is significantly reduced in patients with severe delay. KEY POINTS: • Tubers associated with EEG slow wave activity were significantly more hypoperfused than other tubers, especially after 1 year of age. • Larger and more hypoperfused tubers at 6 months of age were more likely to subsequently be associated with pathological EEG slow wave activity. • Patients with severe developmental delay had more extensive and severe global hypoperfusion than those without developmental delay.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Arterial spin labeling; Child; Longitudinal studies; Magnetic resonance imaging; Tuberous sclerosis

Year:  2022        PMID: 36066730     DOI: 10.1007/s00330-022-09036-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  33 in total

1.  Prognostic significance of tuber count and location in tuberous sclerosis complex.

Authors:  Colin Doherty; Suzanne Goh; Tina Young Poussaint; Namik Erdag; Elizabeth A Thiele
Journal:  J Child Neurol       Date:  2005-10       Impact factor: 1.987

2.  Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study.

Authors:  Ajay Gupta; Gwendolyn de Bruyn; Simon Tousseyn; Balu Krishnan; Lieven Lagae; Nitin Agarwal
Journal:  Pediatr Neurol       Date:  2020-02-04       Impact factor: 3.372

3.  Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex.

Authors:  Magdalena Kaczorowska; Elżbieta Jurkiewicz; Dorota Domańska-Pakieła; Małgorzata Syczewska; Barbara Lojszczyk; Dariusz Chmielewski; Katarzyna Kotulska; Dariusz Kuczyński; Tomasz Kmieć; Dorota Dunin-Wąsowicz; Jolanta Kasprzyk-Obara; Sergiusz Jóźwiak
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

4.  Association between diffuse cerebral MRI lesions and the occurrence and intractableness of West syndrome in tuberous sclerosis complex.

Authors:  Tohru Okanishi; Ayataka Fujimoto; Sotaro Kanai; Satoru Sakuma; Susumu Ito; Kazuo Okanari; Mitsuyo Nishimura; Takayuki Masui; Hideo Enoki
Journal:  Epilepsy Behav       Date:  2019-10-20       Impact factor: 2.937

5.  Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions.

Authors:  Jurriaan M Peters; Maxime Taquet; Anna K Prohl; Benoit Scherrer; Agnies M van Eeghen; Sanjay P Prabhu; Mustafa Sahin; Simon K Warfield
Journal:  Future Neurol       Date:  2013-09

6.  Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

Authors:  A L Numis; P Major; M A Montenegro; D A Muzykewicz; M B Pulsifer; E A Thiele
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

7.  Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex.

Authors:  Patrick F Bolton; Rebecca J Park; J Nicholas P Higgins; Paul D Griffiths; Andrew Pickles
Journal:  Brain       Date:  2002-06       Impact factor: 13.501

8.  Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Maria Montenegro; Elizabeth Thiele
Journal:  Neurology       Date:  2009-03-31       Impact factor: 9.910

9.  Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.

Authors:  Rima Nabbout; Elena Belousova; Mirjana P Benedik; Tom Carter; Vincent Cottin; Paolo Curatolo; Maria Dahlin; Lisa D Amato; Guillaume Beaure d'Augères; Petrus J de Vries; José C Ferreira; Martha Feucht; Carla Fladrowski; Christoph Hertzberg; Sergiusz Jozwiak; John A Lawson; Alfons Macaya; Ruben Marques; Finbar O'Callaghan; Jiong Qin; Valentin Sander; Matthias Sauter; Seema Shah; Yukitoshi Takahashi; Renaud Touraine; Sotiris Youroukos; Bernard Zonnenberg; Anna Jansen; John C Kingswood
Journal:  Epilepsia Open       Date:  2018-12-21

10.  Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.

Authors:  Angelika Mühlebner; Jackelien van Scheppingen; Hanna M Hulshof; Theresa Scholl; Anand M Iyer; Jasper J Anink; Ans M W van den Ouweland; Mark D Nellist; Floor E Jansen; Wim G M Spliet; Pavel Krsek; Barbora Benova; Josef Zamecnik; Peter B Crino; Daniela Prayer; Thomas Czech; Adelheid Wöhrer; Jasmin Rahimi; Romana Höftberger; Johannes A Hainfellner; Martha Feucht; Eleonora Aronica
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.